CVS Health (CVS)
Technical, fundamental, and sentiment analysis with recent related videos.
CVS rates Neutral overall. The fundamental read is neutral: the company passes 5 of 9 quality tests on the Piotroski F-Score; balance sheet is in the Grey zone (Altman Z = 2.31); revenue is growing about 7.6% per year; net income is declining about 1.8% per year. The technical picture is bearish: price is 1.0% above the 200-day moving average; 2.3% below the 50-day; the 50/200 relationship is in a Golden cross. Sentiment is bullish (composite 80/100), based on 6 news articles from recent coverage.
Revenue 3-year avg +7.6%. Net income 3-year avg -1.8%.
Price vs 20DMA -1.8%. RSI 43.51. Bollinger state: Inside Bands.
Composite score 80/100 from the AI judge, based on 6 news items, 0 television segments, and 0 videos.
Latest Market Read
CVS’s three badges split the picture. Fundamental is Neutral: revenue averaged 7.6 percent per year while net income averaged -1.8 percent per year, so revenue growth offsets weakening profits. Technical is Bearish: price sits 1.8 percent below its 20-day moving average, the Relative Strength Index (RSI), a momentum reading, is 43.5, and the stock is trading inside the Bollinger Bands (volatility channel). Sentiment is Bullish with a composite 80/100, but strong sentiment and neutral fundamentals are not enough to overcome the bearish technicals, leaving the overall rating at Neutral.
Recent news: Coverage is broadly positive: CVS reported quarterly results that beat expectations and raised full-year guidance, prompting renewed investor interest and positioning the stock as a defensive dividend play. Articles note a 43.9% three-year return and new institutional buying while also flagging ongoing scrutiny of PBM margins and Aetna integration; GDELT tone is strongly positive and there are no TV or video items to contradict the upbeat news.
Latest Videos
- No qualified videos yet.